Jazz Pharmaceuticals (JAZZ) Land & Improvements (2014 - 2016)
Jazz Pharmaceuticals' (JAZZ) quarterly Land & Improvements came in at $1.8 million in Q1 2016, up 33.19% year-on-year from $1.4 million in Q2 2015, and up 3.55% quarter-over-quarter from $1.8 million in Q4 2015.
Jazz Pharmaceuticals (JAZZ) Land & Improvements (2014 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Land & Improvements history runs 3 years deep, the most recent figure standing at $1.8 million for Q1 2016.
- On a quarterly basis, Land & Improvements rose 33.19% year-over-year to $1.8 million in Q1 2016; TTM through Mar 2016 was $1.8 million, a 33.19% increase from a year earlier, with the FY2015 full-year figure at $1.8 million, up 14.74% from the prior year.
- Land & Improvements rose to $1.8 million in Q1 2016 per JAZZ's latest filing, from $1.8 million in the prior quarter.
- Across five years, Land & Improvements topped out at $1.8 million in Q1 2016 and bottomed at $1.4 million in Q1 2015.
- The 3-year median for Land & Improvements is $1.7 million (2014), against an average of $1.7 million.
- Across the five-year window, Land & Improvements dropped 17.76% in 2015 and jumped 33.19% in 2016, its largest moves.
- Year by year, Land & Improvements stood at $1.5 million in 2014, then gained by 14.74% to $1.8 million in 2015, then gained by 3.55% to $1.8 million in 2016.
- Per Business Quant, the three latest JAZZ Land & Improvements figures stand at $1.8 million (Q1 2016), $1.8 million (Q4 2015), and $1.8 million (Q3 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 1.84 Mn |
| Dec 31, 2015 | 1.78 Mn |
| Sep 30, 2015 | 1.78 Mn |
| Jun 30, 2015 | 1.69 Mn |
| Mar 31, 2015 | 1.38 Mn |
| Dec 31, 2014 | 1.55 Mn |
| Sep 30, 2014 | 1.61 Mn |
| Jun 30, 2014 | 1.69 Mn |
| Mar 31, 2014 | 1.68 Mn |